Clinical Trial

Immunosuppressant Withdrawal Based on Parenchymal Chimerism in the Liver Transplantation

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated July 30, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn whether liver parenchyma chimerism can represent a chievement of operational tolerance in liver transplantation recipients. The researchers will examine the degree of parenchyma chimerism. The participants will withdraw or minimize their immunosuppression to avoid the adverse effects of immunosuppressants.
Trial Details
NCT Number NCT07735650
Lead Sponsor Chang Gung Memorial Hospital
Conditions Liver Transplantation, Liver Transplantation in Long-term
Enrollment 60 participants
Start Date 2025-08-01
Primary Completion 2026-07-31 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-30